Source: Experimental Cell Research. Unidade: ICB
Subjects: IMUNOLOGIA, BIOLOGIA CELULAR, FÁRMACOS IMUNOSSUPRESSORES, CARCINOGÊNESE, PLAQUETAS SANGUÍNEAS, CÉLULAS CULTIVADAS DE TUMOR, CAMUNDONGOS, RNA, FOSFOLIPÍDEOS
ABNT
DALMASO, Barbara et al. Pan-carcinoma data driven analysis reveals platelet-activating factor receptor (PTAFR) involvement in immunosuppressive tumor microenvironment signaling and clinical prognosis. Experimental Cell Research, v. 450, n. 2, 2025Tradução . . Disponível em: https://doi.org/10.1016/j.yexcr.2025.114643. Acesso em: 08 out. 2025.APA
Dalmaso, B., Silva-Junior, I. A. da, Steenpass, L., Pommerenke, C., Jancar, S., & Del Debbio, C. B. (2025). Pan-carcinoma data driven analysis reveals platelet-activating factor receptor (PTAFR) involvement in immunosuppressive tumor microenvironment signaling and clinical prognosis. Experimental Cell Research, 450( 2). doi:10.1016/j.yexcr.2025.114643NLM
Dalmaso B, Silva-Junior IA da, Steenpass L, Pommerenke C, Jancar S, Del Debbio CB. Pan-carcinoma data driven analysis reveals platelet-activating factor receptor (PTAFR) involvement in immunosuppressive tumor microenvironment signaling and clinical prognosis [Internet]. Experimental Cell Research. 2025 ; 450( 2):[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.yexcr.2025.114643Vancouver
Dalmaso B, Silva-Junior IA da, Steenpass L, Pommerenke C, Jancar S, Del Debbio CB. Pan-carcinoma data driven analysis reveals platelet-activating factor receptor (PTAFR) involvement in immunosuppressive tumor microenvironment signaling and clinical prognosis [Internet]. Experimental Cell Research. 2025 ; 450( 2):[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.yexcr.2025.114643